Northwest Biotherapeutics reported $1.52M in Interest Expense on Debt for its fiscal quarter ending in March of 2024.





Interest Expense On Debt Change Date
Agenus USD 16.02M 2.85M Dec/2025
AstraZeneca USD 484M 181M Dec/2025
Bristol-Myers Squibb USD 411M 21M Mar/2026
Eisai JPY 1.55B 117M Mar/2026
Infinity Pharmaceuticals USD 45K 0 Jun/2023
Merck USD 479M 67M Mar/2026
Northwest Biotherapeutics USD 1.52M 276K Mar/2024
Pfizer USD 671M 40M Mar/2026
Plus Therapeutics USD 62K 25K Dec/2023
Roche Holding CHF 304M 7.5M Jun/2025